XML 71 R61.htm IDEA: XBRL DOCUMENT v3.25.3
Acquisitions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Jul. 01, 2025
Apr. 01, 2025
Mar. 31, 2025
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
[1]
Total Consideration:              
Total cash paid, net         $ 156,291,615 $ 0  
Assets acquired              
Goodwill       $ 356,913,957 356,913,957   $ 340,668,927
BioConnect              
Total Consideration:              
Cash paid $ 12,996,275            
Less: cash acquired (113,545)            
Total cash paid, net 12,882,730            
Assets acquired              
Accounts receivable 1,836,809            
Inventory 1,176,471            
Prepaid expenses and other current assets 111,143            
Property, plant, and equipment 63,866            
Goodwill 3,399,491            
Total assets acquired, excluding cash 15,852,486            
Liabilities assumed:              
Accounts payable 603,234            
Accrued expenses and other current liabilities 369,074            
Other liabilities 1,997,448            
Total liabilities assumed 2,969,756            
Measurement Period Adjustments              
Net assets acquired, excluding cash 12,882,730            
BioConnect | Trade names and trademarks              
Assets acquired              
Intangible asset 882,353            
BioConnect | Developed technology              
Assets acquired              
Intangible asset 6,617,647            
BioConnect | Customer relationships              
Assets acquired              
Intangible asset $ 1,764,706            
VOXX International Corporation              
Total Consideration:              
Cash paid   $ 148,256,998          
Less: cash acquired   (9,077,136)          
Total cash paid, net   139,179,862          
Fair value of previously held investment in VOXX   48,478,560 $ 48,500,000        
Total transaction consideration, net   187,658,422          
Assets acquired              
Accounts receivable   56,719,726   56,719,726 56,719,726    
Inventory   96,718,000   96,718,000 96,718,000    
Prepaid expenses and other current assets   20,294,973   20,294,973 20,294,973    
Income tax recoverable   5,243,038   5,243,038 5,243,038    
Property, plant, and equipment   44,977,000   44,977,000 44,977,000    
Equity investment   19,000,000   19,000,000 19,000,000    
Deferred tax asset   32,537,099   32,537,099 32,537,099    
Goodwill   0   12,845,539 12,845,539    
Operating lease, right of use assets   5,404,163   5,404,163 5,404,163    
Other assets   3,445,075   3,445,075 3,445,075    
Total assets acquired, excluding cash   284,339,074   297,184,613 297,184,613    
Liabilities assumed:              
Accounts payable   31,347,556   31,096,255 31,096,255    
Accrued expenses and other current liabilities   51,772,746   64,869,586 64,869,586    
Income taxes payable   684,033   684,033 684,033    
Debt   3,909,290   3,909,290 3,909,290    
Other tax liabilities   791,593   791,593 791,593    
Operating lease liabilities   3,435,604   3,435,604 3,435,604    
Other liabilities   1,260,830   1,260,830 1,260,830    
Total liabilities assumed   93,201,652   106,047,191 106,047,191    
Measurement Period Adjustments              
Goodwill       12,845,539      
Total assets acquired, excluding cash       12,845,539      
Accounts payable       (251,301)      
Accrued expenses and other current liabilities       13,096,840      
Total liabilities assumed       12,845,539      
Net assets acquired, excluding cash       0      
Redeemable and non-redeemable non-controlling interests in consolidated subsidiaries   3,479,000   3,479,000 3,479,000    
Net assets acquired, excluding cash   $ 187,658,422   $ 187,658,422 $ 187,658,422    
[1] The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the inflation and footnotes required by accounting principles generally accepted in the United States for complete financial statements.